Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Stem Cells and Development|May 30, 2024
Mice Hepatic Organoids for Modeling Nonalcoholic Fatty Liver Disease and Drug ResponseZheng Zhou, Xiyan Zheng, Maoyun Xie, et al.Human Cell|May 13, 2026
Bisphosphoglycerate mutase is involved in glucose metabolism and progression of nonalcoholic fatty liver disease based on liver organoidsZheng Zhou, Xiyan Zheng, Xianqing Chen, et al.Stem Cell Research & Therapy|December 24, 2024
Generation of vascularized pancreatic progenitors through co-differentiation of endoderm and mesoderm from human pluripotent stem cellsXiaopu Sang, Junming Xu, Yihang Wang, et al.Langmuir : the ACS Journal of Surfaces and Colloids|December 22, 2025
Hydrodynamic Manipulation of 2D and 3D Microstructure Assembly Using Robotic Acoustic Streaming TweezersXianjie Shi, Sihong Shen, Hongtao Shi, et al.Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|December 15, 2015
[Treatment and prognosis of solid pseudopapillary neoplasms with metastases or recurrence]Mingyue Xu, Xianjie Shi, Tao Wan, et al.Zhonghua Yi Xue Za Zhi|April 17, 2015
[Clinical efficacies of different surgical strategies for advanced pancreatic carcinoma]Shaocheng Lü, Wanqing Gu, Yurong Liang, et al.Zhonghua Yi Xue Za Zhi|January 28, 2016
[Comparison of clinicopathological characteristics and prognosis of intrahepatic biliary cystic tumor between male and female patients]Mingyue Xu, Xianjie Shi, Tao Wan, et al.Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|August 17, 2015
[Clinicopathological characteristics and prognostic factors of intrahepatic biliary cystadenocarcinoma]Mingyue Xu, Xianjie Shi, Tao Wan, et al.International Journal of Biological Macromolecules|December 24, 2024
Molecular and cellular mechanisms of PDAC progression based on RETN-CAP1-mediated macrophage-fibroblast crosstalk: Action of ITGB5 and ITGB1 recombinant proteinsGuangquan Zhang, Xiaozhun Huang, Ruixi Li, et al.Journal of Translational Medicine|May 19, 2026
Identification of the CYP19A1-GPER1 axis as a critical oncogenic driver in hepatocellular carcinoma via AKT activationHang Zhai, Jicai Wang, Yongfei He, et al.Pageof 4